APA (7th ed.) Citation

F, L., X, L., S, C., DG, T., K, M., W, W., . . . SI, A. (2026). DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: Dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers. Journal of experimental & clinical cancer research : CR, 45(1), . https://doi.org/10.1186/s13046-026-03733-3

Chicago Style (17th ed.) Citation

F, Li, et al. "DDX5 (p68) and UbE2T as Emerging Superior Cancer Therapeutic Targets: Dual Molecular Glue Target Degradation by FL118 for Conquering Difficult-to-treat Cancers." Journal of Experimental & Clinical Cancer Research : CR 45, no. 1 (2026). https://doi.org/10.1186/s13046-026-03733-3.

MLA (9th ed.) Citation

F, Li, et al. "DDX5 (p68) and UbE2T as Emerging Superior Cancer Therapeutic Targets: Dual Molecular Glue Target Degradation by FL118 for Conquering Difficult-to-treat Cancers." Journal of Experimental & Clinical Cancer Research : CR, vol. 45, no. 1, 2026, https://doi.org/10.1186/s13046-026-03733-3.